07.09.2010 • News

Gerd Löbbert Appointed Borealis Executive Vice President for Polyolefins

Gerd Löbbert
Gerd Löbbert

Borealis announces the move of Gerd Löbbert from his current position as executive vice president for base chemicals to the position of executive vice president for polyolefins, effective Oct. 1.

Lorenzo Delorenzi, currently executive vice president for polyolefins has decided to leave Borealis by the end of this year and return to Belgium to pursue other career opportunities.

Gerd Löbbert joined Borealis in January as executive vice president for base chemicals. Prior to Borealis, he held various positions at BASF, specifically in the area of pigments, polymers and additives. He was marketing director inks and pigments in the U. S.; vice president, global business unit printing inks and dispersions in Stuttgart, Germany; and group vice president performance chemicals for coatings, plastics and specialities.

From 2005, Löbbert was group vice president, cracker products and industrial gases Europe and in mid- 2009 he took over responsibility for restructuring the worldwide pigment activities, before he joined Borealis.

"We are pleased that we now have the possibility to make use of Gerd's wealth of experience in the chemical and petrochemical industry also in our polyolefins business group. After he set the strategic framework for the base chemicals business development he will now drive the polyolefins business to the next level," comments Borealis chief executive Mark Garrett. "I also would like to extend my appreciation and gratitude to Lorenzo for his committed leadership and guidance of our polyolefin businesses in Borealis and Borouge through a period of exceptional challenges. We wish him all the best for his next career steps."

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.